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 EXPLANATORY  NOTE 
1.  On  21  December  1976  the  Council  adopted  Directive  77/94/EEC  on 
the  approximation  of  the  Laws  of  the  Member  States  relating  to 
foodstuffs  for  particular  nutritional  uses  (1).  Article  1(3) 
of  that  outline  directive  provides  for  the  adoption  of  speci-
fic  directives  applicable  to  certain  groups  of  products  de-
fined  th· rein.  This  proposal  covers  infant  formulae  and 
follow-up  milks  intended  for  particular  nutritional  use  by 
infants  in  good  health.  Products  intended  for  use  by  Low 
birth-weight  infants  and  for  infants  and  young  children 
suffering  from  nutritional  or  metabolic  disorders  are  ex-
cluded  from  the  scope  of  this  proposal. 
2.  Human  milk,  when  available  in  sufficient  quantities,  is  the 
best  food  for  nearly  all  healthy  infants.  But  when  mothers 
choose  or  are  obliged  not  to  breastfeed,  or  to  do  so  par-
tially,  manufactured  preparations  provide  the  best  alter-
n a t i v e •  S  u c h  p rod u c t s  f i r s t  a·p pea r e d  a bout  a  c e n t u r y  a g o 
in  response  to  a  need  for  alternatives  to  a  wet  nurse  or 
to  cow's  milk.  Initially  the  aim  was  to  provide  a  product 
free  from  pathogenic  micro  organisms.  Later,  doctors  re-
cognised  the  problems  associated  with  the  digestibility  of 
cow's  milk  and  started  providing  their  own  blends  of  diluted 
cow's  milk  to  which  they  added  sugar  and  fat.  In  parallel, 
the  importance  of  vitamins  in  the  diet  was  discovered. 
Manufacturers  adopted  the  idea  and  started  producing 
accordingly  modified  preparations.  But  it  was  after  the  second 
World  War  that  most  significant  developments  in  this  area 
started. 
3.  These  products  have  to  respond  to  the  needs  of  the  most  vul-
nerable  section  of  the  population.  Thus,  their  evolution 
followed  closely  advances  in  scientific  knowledge,  in 
medicine,  nutrition  and  other  disciplines  as  has  the  evolution 
'; 
of  Legislation  relating  to  these  products. 
--,--
(1)  O.J.  No  L  26/55  of  31.1.77 ---·--····-···· 
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Within  the  Community,  two  types  of  approaches  exist.  One  l~ys 
down  general  legal  crit~ria to  which  these  products  have  to 
conform  in  order  to  be  marketed  while  the  other  requires  the 
examination  of  each  individual  product  and  its  approval. 
Directive  77/94/EE!  has  retairied  the  first  approach  which 
forms  therefore  the  basis  for  this  proposal. 
4.  The  nature  of  the  products  and  the  population  for  which  they 
were  intended  called  for  careful  asse$sment  of  the  nutritional 
and  other  scientific  evidence  which  should  be  taken  into  con-
sideration  in  laying  down  the.ir  essential  composition.  The 
Scientific  Committee  for  Fo6d  ·(SCF)  was  aske~  to  give  it~ 
opinion  on  the  matter.  The  SCF  was  assisted  in  its  work  by 
eminent  experts  on  the  subject.  It  expressed  its opinion  on 
27  April  1983  (1).  This  opinion  formed  the  basis  for  the 
nutritional  and  technical  specifications  of  this  proposal. 
5.  In  ~ddition,  the  Commission  services,  in  their  preparatory 
w  o r k ,  h a d  t h e  b e n e f i t  o f  t h e  a d v i c e  o f  t h e  A  d v i s o r y  C  o m  m  i t t -e e 
on  Foodstuffs  which  is  composed  of  representatives  of  Agri-
culture,  Commerce,  Consumers,  Industry  and  Workers.  They  also 
consulted  M.ember  States  in  the  usual  way. 
6.  The  great  majority  of  infant  formulae  intended  for  healthy 
infants  existing  presently  in  the  Community  market  are  based 
on  cow's  milk  protein.  A  small  number  of  products  <7-8%  of 
the  market)  is  based  wholly  or  partially  on  other  protein 
sources,  mainly  soya  protein.  The  latter  are  currently  used 
for  infants  which  are  allergic  to  cow's  milk  protein,  suffer 
from  diarrhoea  or  other  conditions.  These  preparations  though 
can  be  used  for  healthy  infants.  However,  additional  scienti-
fic  and  technological  considerations  have  to  be  taken  into 
account  in  laying  down  specific  rules  for  these  products.  The 
Commission  feels  tbat  more  time  is  needed  for  the  evaluation 
(1)  Report  of  SCF  14th  Series. -3-
of  the  data  related  to  these  products  and  intends  to  specify  . 
their  essential  composition  at  a  later  date.  The  problem  does 
not  arise  with  follow-up  milks  since  these  products  are 
exclusively  manufactured  from  cow's  milk  protein. 
7.  At  birth  some  physiological  processes  involved  in  the  di-
gestion.  absorption,  hepatic  functions  and  renal  clearance 
are  not  fully  developed.  The  neonate  therefore  has  a  limited 
tolerance  with  respect  to  certain  nutrients  during  its first 
few  months  of  life.  The  essential  composition  of  infant 
formulae  based  on  cow's  milk  laid  doown  in  Annex  I,  Part  A, 
takes  this  into  account  as  well  as  the  fact  that  this  product 
being  the  sole  source  of  nourishment  for  the  infant  has  to 
supply  him  with  all  the  nutrients  and  the  energy  necessary  for 
growth  and  for  the  development  of  various  tissues. 
8.  In  the  words  of  the  SCF,  "after  the  age  of  about  4  months, 
the  mechanisms  that  ensure  homeostasis  are  sufficiently  deve-
loped  to  cope  with  much  wider  varijtions  in  the  concentration 
of  nutrients".  In  addition,  usually  between  the  age  of  3  and  6 
months,  infants  are  gradually  introduced  to  a  variety  of 
foods.  Thus,  the  milk  preparation,  when  used,  becomes  a  com-
ponent  of  a  progressively  diversified  diet  and  has  to  supply 
only  part  of  the  materials  necessary  for  growth.  Manufacturers 
in  the  Community  have  therefore  developed  a  distinct  product, 
followup  milk,  which  can  be  fed  to  infants  after  the  age 
of  4-6  months.  For  the  above  reasons  the  essential  require-
ments  for  the  Latter  product,  which  are  Laid  down  ~n  Annex  II, 
have  more  flexibility,  especially  with  regard  to  vitamins  and 
mineral  substances,  than  those  for  the  former.  It  must  be 
f 
stressed,  however,  that  infant  formula  is  also  suitable  for 
use  by  infants  above  the  age  of  4-6  months. 
9.  The  essential  requirements  Laid  down  in  Annexes  I  and  II 
j 
refer  to  the  products  ready  for  use.  In  order  that  these  are 
fulfilled  a  number  of  mineral  substances,  vitamins,  amino 
I 
acids  and  other  nitrogen  compounds  have  to  be  added.  Infant -4-
formulae  and  followup  milks  are  manufactured  from  raw  mate-
rials  whose  composition  may  vary  according  to  their  source  or 
may  fluctuate  according  to  the  season.  The  finished  product 
can  be  marketed  as  a  powder  or  as  a  liquid.  Their  method  of 
production  varies  according  to  the  product  and  the  proprietary 
mark.  The  list  of  compounds  which  can  be  added,  given  in 
Annex  III,  is  wide  enough  to  allow  for  these  factors  to  be 
taken  into  consideration.  The  criteria  used  for  the  inclusion 
of  the  compounds  in  this  list  have  been  mainly  the  absence  of 
any  health  risk,  their  good  nutritional  availability,  their 
correct  solubility,  their  stability  and  low  reactivity  with 
other  substances  during  processing,  their  lack  of  colour 
defects  and  unacceptable  taste  effects  and  their  optimal 
storage  stability.  The  technological  needs  for  the  production 
of  these  products  justifies  the  use  of  the  additives  given  in 
Annex  IV,  which  are  acceptable  from  the  point  of  view  of 
health  protection. 
10.Scientific  and  technological  advances  in  the  field  might  ne-
cessitate  future  changes  or .additions  in  the  provisions  of 
Annexes  I,  II,  III  and  IV.  It  is  essential  that  adequately 
proven,  beneficial  technical  modifications  to  this  directive 
should  be  able  to  be  effected  with  the  minimum  of  delay.  The 
contrary  would  be  a  deterrent  for  investing  in  research  and 
seeking  progress  in  the  area.  Article  7  takes  account  of  these 
facts. 
11.The  labelling  provisions  of  Article  9  take  into  account  t~e 
particular  nature  of  the  produts  and  the  relevant  provision 
of  the  International  Code  of  Marketing  of  Breast-milk 
substitutes.  These  products  are  specifically  formulated  to 
meet  the  needs  of  infants  and  the  special  conditions  of  their 
metabolism.  The  use  of  terms  such  as  "humanized",  "mater-
nalized",  "adapted"  and  the  like  which  might  imply  that  these 
products  are  of  an  extra  quality  compared  with  others  is 
prohibited.  On  the  other  hand  the  specific  compositional  cri-
teria  for  which  a  claim  can  be  made  are  defined  in  Annex  V. -5-
12.The  Commission,  with  the  support  of  the  SCF,  is  currently 
examining  infant  formulae  not  or  not  entirely  based  on  cow's 
milk  proteins  and  other  groups  of  foods  for  infants  and  young 
children  with  a  view  to  present  proposals  in  these  areas  in 
the  future. 
13.The  consultation  of  the  European  Parliament  and  the  Economic 
and  Soc~al  Committee  on  this  proposal  is  required  under 
article  100  6f  the  Treaty. Proposal  for  a 
~Q~~~lb_Q!B~~I!~~ 
on  the  approximation  of  the  Laws  of  the  Member  States  relating 
to  infant  formulae  and  follow-up  milks 
THE  COUNCIL  OF  THE  EUROPEAN  COMMUNITIES, 
Havirg  regard  to  the  Treaty  establishing  the  European  Economic  Community, 
and  in particular Article  100  thereof, 
Having  regard  to  Council  Directive  77/94/EEC  of  21  December  1976  on  the 
approximation  of  the  laws  of  the  Member  States  relating  to  foodstuffs 
for  particular nutritional  uses1,  and  in  particular Article  1(3)  thereof, 
Having  regard  to  the  proposal  from  the  Commission, 
Having  regard  to  the  opinion  of  the  European  Parliament, 
Having  regard  to  the  opinion  of  the  Economic  and  Social  Committee, 
Whereas  infant  formulae  and  follow-up  milks  intended  for  particular 
nutritional  use  by  infants  in  good  health  form  a  very  important  group 
within  the  category  of  foodstuffs  for  particular nutritional  uses; 
Whereas  a  specific  Directive  within  the  meaning  of  Article  1(3)  of 
Directive  77/94/EEC  should  therefore  be  adopted  for  this  group  of 
products; 
Whereas  the  essential  composition  of  the  products  in  question  must 
satisfy the  nutritional  requirements  of  infants  as  established  by 
generally accepted  scientific  data; 
Whereas  on  the  basis  of  these  data  the  essential  composition  of  infant 
formulae  manufactured  from  cows'  m1lk  proteins  can  already  be  defined; 
whereas  the  same  is  not  true  for  preparations  based  wholly  or  partly 
on  other  sources  of  protein;  whereas  specific  rules  for  such  products 
will  therefore  have  to  be  adopted  at  a  Later  date; 
Wher~as follow-up  milks  currently  sold  in  the  Community  are  manufactured 
exclusively  from  cows'  milk;  whereas  the  scope  of  this  Directive 
should  therefore  be  restricted to  that  type  of  product  for  the  time  being; 
1  OJ  No  L  26,  31.1.1977,  p.  55. - 2 -
Whereas  should  follow-up  p~oducts not  or  not  exclusively  based  on  cows' 
milk  Later  appear  on  the  market  the  advisability of  adopting  common 
rules  for  them  would  have  to  be  examined; 
Whereas  pursuant  to  Article  5(1)  of  Directive  77/94/EEC  the  products 
covered  by  this  Directive  are  subject  to  the  general  rules  Laid  down 
by  Council  Directive  79/112/EEC  of  18  December  1978  on  the 
approximation  of  the  Laws  of  the  Member  States  relating  to  the  Labelling, 
presentation  and  advertising  of  foodstuffs  for  sale  to  the  ultimate 
1  consumer  ;  whereas  this  Directive  need  do  no  more  than  adopt  the 
additions  and  exceptions  to  those  general  rules; 
Whereas,  in  particular, the  nature  and  destination of  the  products 
covered  by  this  Directive  require nutritional  Labelling  for  the energy 
•i 
value  and  principal  nutrients  they  contain;  whereas  on  the other hand,  the 
method  of  use  must  be  specified  in  conformity  with  Article  3(1), 
point  8  and  Article 10(~ of  Directive  79/112/EEC,  in  order  to prevent 
inappropriate  uses  Likely  to  be  detrimental  to  the  health  of  infants; 
Whereas,  in  application  of  Article  2(2)  of  Directive  79/112/EEC,  and 
in  order  to  supply  objective  and  scientifically verified  information, 
it  is  necessary  to  define  the  conditions  under ·which  claims  about  the 
particular  composition  of  an  inf~nt  formula  are  authorized; 
Whereas,  in  an  effort to provide  bett~r protection  for  th9  health  of  in-
fants,  the  rules  of  composition  and  Labelling  laid  down  in this Directive should 
also  take account  of  the  principles  and  the  aims  of  the  International 
Code  of  Marketing  of  Breast-Milk  Substitutes  adopted  by  the  34th  World 
Health  Assembly,  bearing  in  mind  the  particular  Legal  and  factual 
situations existing  in  the  Community; 
Whereas  the  adaptation  of  this  Directive  to  scientific  and  technical 
progress  is  an  implementing  measure  that  should  be  delegated  to  the 
Commission;  whereas  it  is  nevertheless  advisable  to  allow  the  Member 
States  to  help  find  a  Community  solution  by  adopting  temporary 
I· 
measures;  whereas  the  procedure  Laid  down  in  Article  9  of 
Directive  77/94/EEC  is  appropriate  for  this  purpose  since  it offers 
close  cooperation  between  the  Member  States  and  the  Commission, 
1  OJ  No  33,  8.2.1979,  p.  1. - 3  -
HAS  ADOPTED  THIS  DIRECTIVE: 
Article  1 
1.  This  Directive  is  a  specific  Directive  within  the  meaning  of 
Article  1(3)  of  Directive  77/94/EEC.  It  shall  apply  to 
"infant  formulae"  and  "follow-up milks"  intended  for  particular 
nutritional  use  by  infants  in  good  health. 
2.  For  the  purposes of  this  Directive, 
(a)  "infant  formulae"  shat l  mean  foodstuffs  intended  for 
particular nutritional  use  by  infants  during  the first  four 
to six months  of  life and  satisfying by  themselves  the 
nutritional  requirements  of  this  category  of  persons; 
(b)  "follow-up milks"  shall  mean  foodstuffs  intended  for 
particular nutritional  use  by  infants  aged  over  four  months 
and  constituting the  milk  element  in  a  progressively 
diversified diet  of  this  category of persons. 
Article  2 
Member  States shall  take all necessary steps to  ensure  that  the products 
referred to  in  Article 1(2)  may  be  marketed  only if they  conform  to the 
definitions  and  rules  laid down  in  this  Directive. 
Ar_t i cl.e  3 
1.  Infant  formulae  shall  be  manufactured  from  food  ingredients  whose 
suitability for  particular nutritional  use  by  infants  from  birth 
has  been established  by  generally accepted scientific data. -4-
2.  Follow-~p milks  shall  be  manufactured  from  cows'  milk  and,  where 
appropriate,  other  food  ingredients  whose  suitability for  particular 
nutritional  use  by  infants  aged  over  four  months  has  been 
established by  generally accepted scientific data. 
3.  The  prohibitions  and  limitations on  the  use  of  food  ingredients  laid 
down  in  Annexes  I  and  II  shall  be  observed. 
Article  4 
1.  Infant  formulae  must  comply  with  the  compositional  criteria 
specified  in  Annex  I. 
However,  the  criteria for  the  compositional  crit~ria for  infant 
formulae  that  are  not  or  not  exclusively  manufactured  from  cows'' 
milk  proteins  shall  be  specified  at  a  later date  in  accordance 
with  Article  100  of  the  Treaty. 
2.  Follow-up  milks  must  comply  with  the  compositional  criteria 
specified  in  Annex  II. 
3.  In  order  to  make  infant  formulae  and  follow-up  milks  ready  for  use, 
nothing  more,  as  the  case  may  be~  than  the  addition  of  water  shall 
be  required. 
Article  5 . 
Only  the  substances  listed  in  Annex  III  may  be  used  for  the  enrichment 
of  infant  formulae  and  follow-up  milks  with: 
mineral  substances 
vitamins 
amino  acids  and  other nitrogen  compounds 
other  substances  having  a  particular nutritional  purpose. 
Article 6 
For  the  manufacture  of  infant  formulae  and  follow-up  milks,  only  the 
additives  listed  in  Annex  IV  may  be  used, 
laid down  therein are met. 
provided the  conditions 
.1. -5-
Article  7 
1.  To  take  account  of  scientific or  technical  developments  subsequent 
to the  adoption of  this  Directive,  a  Member  State  may  authorize 
within  its territory: 
the  observance of  essential  compositionaL  criteria that  are 
new  or differ  from  those  in  Annexes  I  and  II, 
the  use  of  substances  not  mentioned  in  Annexes  III and  IV, 
the  widening  of  the  conditions of  use  in  Annex  IV, 
subject  to the  following  conditions: 
(a)  the  authorization must  be  limited to a ·maximum  period of 
three  years; 
(b)  the  Member  State must  carry  ~ut an  official  check  of 
products  manufactured  in  accordance vith the authorization; 
(c)  products  thus  manufactured  must  bear  a  distinctive 
indication  which  is to be  defined  in the authorization. 
2.  The  Member  States  shall  forward  to  the other  Member  States  and  to 
'the  Cotnmi·ssion  t·he  text  of  any  au'thori zation  drawn  up  pursuant  to 
paragraph  1  ·~ithin two  months  of  the date  of  its taking effect. 
3.  Before  the  expiry of  the three-year period provided for  in paragraph  1, 
the  Member  State may  submit  to the  Commission  a  request  for  the 
admission  in this  Directive of  the  elements  that are  the  subject 
of national  authorization in  accordance  with  paragraph  1.  At  the 
same  time  it shall  supply  supporting documents  setting out  the 
grounds  on  which  it deems  such  admtssion  justified. 
Within  18 months  of  the  submission  of  the  request,  a  decision  shall 
be  taken on  the basis  of  technical  data  and  information  relating 
to public  health,  where  necessary after consulting  the Scientific 
Committee  for  Food,  and  in  accordance  with  the procedure  laid 
down  in  Ar~icle 9  of  Directive  77/94/EEC  as  to  whether  the  elements 
in question  may  be  admitted  in  this.Directive or  whether  the 
national authorization  should  be  revoked.  By  way  of derogation fran 
paragraph  1(a), the national  authorization  shall  remain  in force 
until  a  decision  is  taken  on  the  request  for  admission  in  this 
Directive. - 6  -
Should  it  be  decided  pursuant  to  the  preceding  subparagraph  that 
the  national  authorization  should  be  revoked,  this decision  shall 
apply  simultaneously  to  any  authorizations  given  by  another  Member 
State  for  the  same  subject. 
Article  8 
1.  Infant  formulae  and  follow-up  milks  shall  not  contain  any  sttbstance 
in  such  quantity  as  to  endanger  the  health  of  infants.  The 
maximum  Levels  of  any  such  substances  shall  be  stipulated at  a 
Later  Jate  in  accordance  with  Article  100  of  the  Treaty. 
2.  Microbiological  standards  shall  be  established  according  to  the 
referred  to  in  paragraph  1. 
Article  9 
1.  The  name  under  which  the  products  covered  by  ArticLe  1  are  sold sha~l be, 
respectively,  "infant  formula"  and  "follow-up  milk"· 
2.  The  Labelling  of  infant  formulae  and  follow-up  milks  shall bear,  in 
addition  to  those  foreseen  in  Article  3  of  Directive  79/112/EEC, 
the  following  mandatory  particulars: 
(a)  in  the  case  of  infant  formulae. generally,  a  statement  to  the 
effect  that  the  product  is suitable  for  particular nutritional 
use  by  infants  from  birth; 
(b)  in  the  case of  infant  formulae  that  do  not  contain added  iron, 
a  statement  to  the  effeit that,  when  the  product  is given  t~ 
infants  over  the  age  of  six  months,  their  total  iron 
requirements  must  be  met  from  other  additional  sources; 
(c)  in  the  case  of  follow-up  milks,  a  statement  to  the  effect  that 
the  product  is suitable  for  particular nutritional  use  by 
infants  over  the  age  of  four  months  and  that  it  should  form 
part  of  a  diversified diet; -7-
(d)  the available energy value; expressed  in  kJ  and  kcal,  and  the 
content  of  proteins,  lipids  and  carbohydrates  per  100  ml  of  the 
product  ready  for  use; 
(e)  the  average  quantity of  each  mineral  substance and  of  each  vitamin 
mentioned  in  Annex  I  and  Annex  II  respectively,  and  where  applicable, 
of  choline,  per  100 ml  of-~he product  ready  for  use; 
(f)  instructions  for  appropriat~ preparation of  the  product; 
(g)  a  statement  to  the effect that it is  important  for .the  infant's 
health that  these  instructions be  followed; 
(h)  information making  possible  batch  identification. 
3.  The  labelling of  infant  formulae  shall  in  addition  bear  the  following 
mandatory particulars: 
(a)  a  statement  concerning the superiority of  breast-feeding; 
(b)  a  statement  recommending  that  the  product  be  used  only  on  the 
advice of  per~ons having qualifications  in  medi~ine, nutrition or 
pharmacy. 
4.  The  labelling of  infant  formulae  and  follow-up  milks  and  the  methods 
used  must  not  idealize  the  use  of  the  products.  The  use  of  the 
terms  "humaniz~d", "maternalized",  "adapted" or  similar  terms shall  be 
prohibited. 
The  implementing  provisions  for  t~is paragraph  shall  be  adopted, 
where  necessary,  in  accordance  with  the  procedure  laid  down  in Article 9 
of  Directive  77/94/EEC. 
5.  The  labelling  m~y bear  claims  concerning the special  composition 
an  infant  formula  only  in  the  cases  Listed  in 
Annex  V and  in  accordance  with  the  conditions  laid down  therein. 
Any  amendments  that  have  to be  made  to that  Annex  in  line  with 
£cientific and  technical  progress  shall  be  adopted  in  accordance  with 
the  procedure  laid down  in  Article 9  of  Directive  77/94/EEC. 
6.  The  prohibitions  and  restrictions  referred to  in  paragraphs  4  and  5 
shall also  apply to: 
.1. -8-
(a)  the  presentation of  infant  formulae  and  follow-up  milks,  in 
particular their shape,  appearance  or  packaging,  the 
packaging  materials  used,  the  way  in  which  they are  arranged 
and  the  setting  in  which  they are displayed; 
(b)  advertising. 
7.  This  Article  shall  also  apply  to infant  formulae  and  follow-up 
milks  for  export  outside the  Carmunity1  in  so  far  as  this  is not 
precluded by  provisions  in  the  importing  country. 
Article 10 
1.  Where  a  Member  State,  as  a  result  of  new  information or of  a  reassess-
ment  of  existing  information  made  since this  Directive  was  adopted~ 
has  detailed grounds  for  establishing that  the  use  in  infant  form~l~~ 
or follow-up  milks  of  one  of  the  substances  listed  in  Annexes  III 
and  IV  or  the  maximum  permissible  concentration  thereof  endangers 
human  health  although  it complies  with  this  ~irective, that  Member. 
State  may  temporarily  suspend or  restrict  application of  the 
provisions  in  question  within  its territory.  It shall  immediately 
inform  the  other  Member  States  and  the  Commission  thereof  and  give 
reasons  for  its decision. 
2.  The  Commission  shall  examine  as  soon  as  possible  the  grounds  given 
by  the  Member  State  concerned  and  consult  the  Member  States  within 
the  Standing  Committee  for  Foodstuffs,  and  shall  then  deliver its 
opinion  forthwith  and  take  the  appropriate measures. 
3.  If the  Commission  considers  that  amendments  to this  Directive 
are  necessary  in  order to  resolve  the difficulties mentioned  in 
paragraph  1  and  to  ensure  the protection of  human  health,  it shall 
initiate the  procedure  laid dowh  in  Article 9  of  Directive 77/94/EEC 
with  a  view  to adopting  those amendments;  in  such  cases,  any 
Member  State which  has  adopted  safeguard  measures  may  in  that 
event  retain  them  until  the date  on  which  the  amendments  are 
to  be  applied. 
.1. - 9  -
Article  11 
Member  States  shall  take  the  necessary  measures  to  comply  ~ith this 
Directive.  They  shall  fo~fhwith  inform  the  Commission  thereof. 
Those  measures  shall  be  applied  in  ~uch a  way  as  to: 
- permit,  by  1  January  1986'at  the  latest,  trade  in  products 
complying  with  this  Directive, 
prohibit,  on  1  July  1987,  trade  in  products  which  do  not  comply 
..  { .. 
with  this  Directive. 
Article  12 
This  Directive  is  addressed  to  the  Member  States. 
Done  at 
For  the  Council 
The  President ANNEX  I 
ESSENTIAL  COMPOSITION  OF  INFANT  FORMULAE 
N.B.:  The  values  given  refer  to  the  products  ready  for  use. 
PART  A 
FO~MULAE  MANUFACTURED  ENTIRELY  FROM  COWS'  MILK  PROTEINS 
1.  Energy 
Minimum 
250  kJ 
(60  kcal)/100  ml 
Maximum 
315  kJ 
(75  kcal)/100  ml 
2.  Proteins  (Protein  content  = nitrogen  content  x  6.38) 
2.1  Formulae  manufactured  from  unmodified  cows'  milk  proteins 
Minimum 
0.56g/100  kJ 
(2.25g/100  kcal) 
Maximum 
O.?g/100  kJ 
(3g/100  kcal) 
- The  chemical  index  of  the proteins present  shall  be  equal  to 
at  Least  80%  of  that  of  the  reference  protein  (human  milk, 
as  defined  in Part  I  of  Annex  VI);  nevertheless,  for 
calculation purposes,  the  concentrations  of  methionine  and 
cystine  may  be  added  together; 
-The "chemical  index"  shall  mean  the  Lowest  of  the  ratios  between 
the  amino  acids  of  the  proteins present  and  the  corresponding 
amino  acids  of  the  reference protein. -2-
2.2  Formulae  manufactured  from  modified  cows'  milk  proteins 
(alteration of  the  casein/~h~y protein  ratio)·· 
Minimum 
0.45g/100  kJ 
( 1 • 8g /1 00  k c a U 
Maximum 
0. ?g/100  kJ 
C3g/100  kcal) 
For  an  equal  energy  value,  the  formula  must  contain  an  available 
quantity of  each  essential  and  semi-essential  amino  acid  at  Least 
equal  to  that  contained  in  t~e reference protein  (human  milk  ~s 
defined  in  Part  I  of  Annes  VI). 
2.3  In  both  cases,  the  addition  of  amino  acids  is permitted  solely 
for  the purpose  of  improving  the  nutritional  value  of  the  milk 
proteins,  and  only  in  the proportions  necessary  for  that  purpose. 
3.  Lipids 
Minimum 
0.8g/100  kJ 
(3.3g/100  kcal) 
I~ ax i mum 
1.Sg/100  kJ 
C6.5g/100  kcal) 
3.1  The  use  of  the  following  substances  is prohibited: 
- sesame  oil; 
- cotton oil; 
- fats  containing  more  than  8%  trans  isomers  of  fatty  acids. 
3.2  Lauric  acid: 
Minimum  Maximum 
15%  of  the  total  fat 
content -3-
3.3  Myristic  acid: 
Minimum  Maximum 
15%  of  the  total 
fat  content 
3.4  Linoleic  acid  (in the  form  of  glycerides = linoleates): 
Minimum 
70  mg/100  kJ 
(300  mg/100  kcal) 
4.  Carbohydrates 
Minimum 
1.  7  g/1 00  kJ 
(7  g/100  kcal) 
3.4 g/100  kJ 
Maximum 
285  mg/100  kJ 
(1200  mg/100  kcal) 
Maximum 
(14  k/100  kcal> 
4.1  Only  the  following  carbohydrates  may  be  used: 
lactose; 
Maltose; 
sucrose; 
malto-dextrins; 
pre-cooked  starch  ~  Naturally  free  of  gluten 
gelatinised starch  ~ 
4.2  Lactose 
Minimum 
0.85  g/100  kJ 
(3. 5  g/1 00  kca L> 
4.3  Sucrose: 
Minimum 
Maximum 
Maximum 
20%  of  the total 
carbbhydrate  ~ontent 
.1. -4- A- - I 
4.4  Pre-cooked  starch  and/or gelatinised starch: 
Minimum 
5.  Mineral  substances 
Sodium  (mEq) 
Potassium  <mEq) 
Chloride  (mEq) 
Calcium  (mg) 
Phosphorus  (mg) 
MagnesiuiA  (mg) 
1  Iron  (mg) 
Zinc  (mg) 
Copper  (J-Ig) 
Iodine  (J-Ig) 
per  100  kJ 
Minimum 
0.25 
0.4 
0.35 
12 
6 
1.2 
0.12 
0.07 
1.2 
Maximum 
0.6 
0.9 
0.8 
22 
3.6 
-0.36 
19 
Maximum 
2  g/100  ml,  and 
30%  of  the total 
carbohydrate 
content 
per  100  k.::a l 
Minimum 
1 
1.6 
1.4 
50 
25 
5 
0.5 
0.3 
20 
5 
Maximum 
2.6 
3.8 
3.5 
90 
15 
1.5 
80 
The  calcium/phosphorus  ratio shall  not  be  less  than  1.2  nor  greater 
than  2.0. 
1Limit  applicable  to  form~lae with  added  iron. 6.  Vitamins 
1  Vitamin  A Y<g  RE) 
2  Vitamin  D  ~g) 
Thiamine  Y,.g) 
Riboflavin  ~g) 
Nicotinamide  0Ug-NE)3 
Pantothenic  acid  SlAg) 
Vitamin s6  y.tg) 
Biotin  ~g) 
Folic  acid  ~g) 
Vitamin s12 
~g) 
Vitamin  C (mg) 
4  Vitamin  E  (mgoc-TE) 
-5-
per  100  kJ 
Minimum 
14 
0.25 
10 
14 
60 
70 
9 
0.4 
1 
0.025 
1. 9 
D. 5/g of 
poly  unsaturated 
fatty acids 
Maximum 
43 
0.5 
expressed  as  Linoleic 
acid  but  in  no  case 
Less  than  0.1  mg/100 
available  kJ 
1RE  = all  trans  retinol  equivalent. 
A  L 
per  100  kcal 
Minimum·  Maximum 
60  180 
1  2 
40 
60 
250 
300 
35 
1.5 
4 
0. 1 
8 
0. 5/g of 
poly  unsaturated 
fatty  acids  expressed 
as  Linoleic  acid  but 
in  no  case  Less 
than 0.5  mg/100 
available  kcal 
2rn  the  form  of  cholecalciferol,  of  which  1D;c-g  = 400  i.u.  of  vitamin  D. 
3NE  = Niacin  equivalent  = mg  nicotinic  acid  +  mg  tryptophan/60. 
4oe-TE  = d-cx·-tocopherol  equivalent. -6-
PART  B 
FORMULAE  NOT  OR  NOT  EXCLUSIVELY  MANUFACTURED  FROM  COWS'  MILK  PROTEINS 
(To  be  completed  later in  accordance  with  the  second  paragraph  of 
Article 4(1)). ANNEX  II 
ESSENTIAL  COMPOSITION  OF  FOLLOW-UP  MILKS 
N.B.:  The  values  given  refer  to  the  products  ready  for  use. 
1.  Energy 
Minimum  Maximum 
250  kJ  335  kJ 
(60  kca L) /100  ml  (80  kcal)/100  ml 
2.  Proteins  (Protein  content  = nitrogen  content  x  6.38) 
Minimum  Maximum 
0.5  g/100  kJ 
<2.25g/100  kcal) 
1g/100  kJ 
(4.5g/100  kcal) 
-The  chemical  index  of  the proteins present  shall  be  at  least  equal 
to  85%  of  that of  the  reference protein  (casein  as  defined  in  Part  II 
of  Annex  VI>. 
- The  "chemical  index"  shall  mean  the  lowest  of  the  ratios  between  the 
amino  acids  of  the  proteins present  and  the  corresponding  amino  acids 
of  the  reference protein. 
-Amino  acids  may  be  added  to  follow-up  milks  for  the purpose  of 
improving  the nutritional  value  of  the  milk  proteins,  in  the 
proportions  necessary  for  that  purpose. 
3.  Lipids 
Minimum 
0.8g/100  kJ 
(3.3g/100  kcal) 
Maximum 
1.5g/100  kJ 
(6.5g/100  kcal) -2-
3.1  The  use of  the  following  substances  is prohibited: 
sesame  oil; 
cotton oil; 
fats  containing more  than  8%  trans  isomers  of  fatty acids. 
3.2  Lauric  acid: 
·Minimum  Maximum 
15%  of  the total  fat 
content 
3.3  Myristic  acid: 
Minimum  Maximum 
15%  of  the total fat 
content 
3.4  Linoleic  acid  (in  the  form  of  glycerides = linoleates): 
Minimum 
70  mg/100  kJ 
(300  mg/100  kcal);  this 
limit  applies  only  to 
follow-up  milks  containing 
vegetable oils 
4.  Carbohydrates 
Minimum 
1o7  g/100  kJ 
(7 g/
1 00  k'caU 
Maximum 
Maximum 
3.4 g/100  kJ 
(14  g/100  kcaL> 
4.1  The  use of  ingredients  containing gluten  is prohibitP.d  • 
. I. 5. 
-3- A- .  I\ 
4.2  Lactose: 
Minimum 
0.45  g/100  kJ 
(1.8 g/100  kcal> 
Maximum 
4.3  Sucrosei  Fructose,  Honey: 
Minimum  Maximum 
Separately or  as  a  whole 
20%  of  the total 
carbohydrate  content 
Mineral  substances 
5.1 
5.2 
5.3 
Iron: 
Minimum 
0.25  mg/100  kJ 
(1  mg/100  kcal) 
Zinc: 
Minimum 
0.12  mg/100  kJ 
(0.5  mg/100  kcal> 
Other  mineral substances: 
Maximum 
0.5  mg/100  kJ 
(2  mg/100  kcal> 
Maximum 
The  concentrations  normally  found  in  cows•  milk,  reduced, 
where  appropriate,  in  the  same  ratio as  the protein 
concentration of  the  follow-up  milk  to that  of  cows•  milk. 
The  typical  composition  of  cows'  milk  is given,  for 
guidance,  in  Annex  VII. 
5.4  The  calcium/phosphorus  ratio  sh~ll not  exceed  2.0  • 
• 1. 6.  Vitamins 
Vitamins  A  (~g  RE>1 
.  2 
Vitamin  0  <jJg> 
Vitamin  C  (mg) 
Vitamin  E  (mg  oc  - TE) 3 
-4-
per  100  kJ 
Minimum 
14 
0.25 
1.9 
0.5/g 
of 
Maximum 
43 
0.5 
of  poly  unsatur-
ated fatty acids 
e.xpressed  as 
Linoleic  acid but 
in  no  case  Less 
than  0.1  mg/100 
available  kJ 
1RE  = all  trans  retinol  equivalent~ 
A. II 
per  100  kcal 
Minimum 
60 
1 
8 
0.5/g 
of 
Maximum 
180 
2 
of  poly  unsaturated 
fatty acids  expressed 
as  Linoleic  acid  but 
in  no  case  Less  than 
0.5  mg/100  available 
kcal 
2rn  the  form  of  cholecalc1fProl,  of  which  10  ~g = 400  i.u. of  vitamin  D. 
3 0<.-TE  = d-e<.  -tocopherol  equivalent. ANNEX  III 
SUBSTANCES  WITH  A SPECIFIC  NUTRITIONAL  PURPOSE  THAT  MAY  BE  USED  IN 
INFANT  FORMULAE  AN~ FOLLOW-UP  MILKS 
PART  I  - MINERAL  SALTS 
Mineral  substances 
1 •  C  a L  c i um  (a) 
2.  Phosphorus  (p) 
3.  Magnesium  (Mg) 
Permitted  salts 
Calcium  carbonate 
Calcium  chloride 
Calcium  citrate 
Calcium  gluconate 
Calcium  glycerophosphate 
Calcium  Lactate 
Calcium  phosphate,  monobasic 
Calcium  phosphate,  dibasic 
Calcium  phosphate,  tribasic 
Calcium  hydroxide 
Calcium  phosphate,  monobasic 
Calcium  phosphate,  dibasic 
Calcium  phosphate,  tribasic 
Magnesium  phosphate,  dibasic 
Magnesium  phosphate,  tribasic 
Potassium  phosphate,  monobasic 
Potassium  phosphate,  dibasic 
Sodium  phosphate,  dibasic 
Magnesium  carbonate 
Magnesium  chloride 
Magnesium  oxide 
Magnesium  phosphate,  dibasic 
Magnesium  phosphate,  tribasic 
Magnesium  sulphate 
Magnesium  gluconate 4.  Iron  (Fe) 
5.  Copper  (Cu) 
6.  Iodine  (I) 
7.  Zinc  (Zn) 
8.  Manganese  (Mn) 
9.  Sodium  (Na) 
-2-
Ferrous  citrate 
Ferrous  gluconate 
Ferrous  lactate 
Ferrous  sulphate 
Ferric  ammonium  citrate 
Cupric  citrate 
Cupric  gluconate 
Cupric  sulphate 
Copper  Lysine  Complex 
Copper  carbonate 
Potassium  iodide 
Sodium  iodide 
Potassium  iodate 
Zinc  acetate 
Zinc  chloride 
Zinc  lactate 
Zinc  sulphate 
Zinc  citrate 
Manganese  carbonate 
Manganese  chloride 
Manganese  citrate 
Manganese  sulphate 
Manganese  gluconate 
Sodium  bicarbonate 
Sodium  chloride 
Sodium  citrate 
Sodium  gluconate 
Sodium  carbonate 
Sodium  Lactate 
Sodium  phosphate,  monobasic 
Sodium  phosphate,  dibasic 
Sodium  phosphate,  tribasic 
Sodium  hydroxide 10.  Potassium  (K) 
PART  II  - VITAMINS 
Vitamin 
1.  Vitamin  A 
2.  Vitamin  D 
3.  Vitamin  81 
4.  Vitamin  82 
5.  Nicotinamide 
6.  Vitamin  86 
7.  Folic  acid 
8.  Pantothenic  acid 
9.  Vitamin  812 
-3- ,,, 
Potassium  bicarbonate 
Potassium  carbonate 
Potassium  chloride 
Potassium  citrate 
Potassium  gluconate 
Potassium  Lactate 
Potassium  phosphate,  monobasic 
Potassium  phosphate,  dibasic 
Potass'i urn  phosphate,  tribasic 
Potassium  hydroxide 
V.  .  f  L  .. 1  1tam1n  ormu  at1on 
Vitamin  A acetate 
Vitamin  A palmitate 
Beta-carotene  (Provitamin  A) 
Vitamin 
Vitamin 
Vitamin 
D 2  <Ergocalciferol) 
D 3 
(Cholecalcif~rol) 
D 3- Cholesterol 
Thiamine  hydrochloride 
Thiamine  mononitrate 
Riboflavin 
Riboflavin  5
1-phosphate  sodium 
Niacinamide 
Nicotinic  acid  (niacin) 
Pyridoxine  hydrochloride 
Pyridoxal-5'-phosphate 
Folic  acid 
D-calcium  pantothenate 
D-~odium pantothenate 
D-panthenol 
Cyanocobalamin 
~ydroxocobalamin -4-
10.  Vitamin  H 
11.  Vitamin  C 
12.  Vitamin  E 
13.  Vitamin  K 
d-Biotin 
L-ascorbic  acid 
Sodium-L-ascorbate 
Calcium-L-ascorbate 
l-ascorbyl-6-palmitate 
Potassium  ascorbate 
d-alpha-tocopherol 
dl-alpha-tocopherol 
d-alpha-tocopherol  acetate 
dl-alpha-tocopherol  acetate 
Vitamin  K 1 
1The  following  substances  may  be  added  to  vitamin  formulations,  for 
technological  reasons. 
- edible  substances 
- gelatine 
the  additives  listed  in  Annex  IV 
- gum  arabic 
-silicon dioxide (maximum  concentration:  10  g/kg) -5-
PART  III  - AMINO  ACIDS  AND  OTHER  NITROGEN  COMPOUNDS 
L  arginine  and  its hydrochloride 
L  cystine  and  its  hydrochloride 
L  histidine  and  its hydrochloride 
L  isoleucine 
L  Leucine 
L  Lysine 
L  and  DL  methionine 
L  phenylalanine 
L  threonine 
L  tryptophan 
L  tyrosine 
L  valine 
taurine 
PART  IV  - OTHER  SUBSTANCES 
Choline  (choline  chloride) 
A  .  ! u_ ANNEX  IV 
ADDITIVES 
N.B.:  The  Limits  given  refer  to  the  products  ready  for  use. 
Additives 
- L-ascorbic  acid 
- Sodium-L-ascorbate 
- Calcium-L-ascorbate 
- Ascorbyl  palmitate 
-Tocopherol-rich extracts of 
natural  origin 
- Synthetic  Alpha-tocopherol 
- Synthetic  Gamma-tocopherol 
- Synthetic  D~Lta-tocopherol 
- Lecithin 
- Mono- and  diglycerides  of 
fatty acids 
(E  300) 
(E  301) 
(E  302) 
(E  304) 
(E  306) 
(E  307) 
(E  308) 
(E  309) 
(E  322) 
(E  471) 
Conditions  of  use 
In  a  concentration,  taken 
either  separately or  together, 
of  not  more  than  1mg/100  ml 
in  infant  formulae  and 
follow-up  milks 
In  a  concentration  of  not 
more  than  O.Sg/100  ml  in 
infant  formulae  and 
follow-up  milks1 
In  a  concentration of  not 
more  than 0.4g/100  ml  in 
infant  formulae  and 
folLow-up  milks  1 
1where  substances  E 322  and  E 471  are  used  together,  the  amount  of  each 
of  them  actually  used  shall  represent  only  part  of  the  maximum 
concentration  ~nd shall  be  such  that  the  sum  of  the  two  fractions  does  not 
exceed  one. -:- Carrageenan 
- Locust  bean  gum 
- Guar  gum 
- Citric  acid 
- L(+)  lactic acid 
- Cultures  producing 
L(+)  lactic acid 
-2-
(E  407) 
(E  410) 
(E  412) 
In  a  concentration of  not  more 
than  0.03g/100  ml  in 
follow-up  milks1 
In  a  concentration  of  not  more 
than  U.1g/100  ml  in  follow-~h~ 
milks1 
In  a  concentration of  not  more 
than  0.1g/100  ml  in  follow-up 
milks  1 
1  .  .  Where  substances  E 407,  E 410  and  E 412  a~e used  together,  the  amount 
of  each  of  them  actually  used  shall  represent  only  part  of  the  maximum 
concentration  and  shall  be  such  that  the  sum  of  the  fractions  does  not 
exceed  one. ANNEX  V 
CLAIMS  CONCERNING  A SPECIFIC  COMPOSITIONAL  CRITERION  FOR  INFANT  FORMULAE 
Compositional  criterion 
- Proteins 
- Sodium 
- Sucrose 
- Lactose 
- Iron 
Conditions  warranting  a  claim 
The  protein  content  is  Lower 
than  0.6g/100  kJ  <Z.Sg/100  kcal) 
and  the  whey  protein/casein  ratio 
is  not  Less  than  1.0. 
The  sodium  content  is  Lower  than 
0.4mEq/100  kJ  (1.7  mEq/100  kcal) 
No  sucrose  is present 
Lactose  is the only  carbohydrate 
used 
The  iron  is  added ANNEX  VI 
REFERENCE  PROTEINS 
PART  I  - HUMAN  MILK 
mg/100  kJ  mg/100  k cal  g/100g  of  protein 
Arginine  16  69  3.8 
Cystine  6  24  1. 3 
Histidine  11  45  2.5 
Isoleucine  17  72  4.0 
Leucine  37  156  8.5 
Lysine  29  122  6.7 
Methionine  7  29  1. 6 
Phenylalanine  15  62  3.4 
Threonine  19  80  4.4 
Tryptophan  7  30  1. 7 
Tyrosine  14  59  3.2 
Valine  19  80  4.5 Arginine 
Cystine 
Histidine 
Isoleucine 
Leucine 
Lysine 
Menthionine 
Phenylalanine 
Threonine 
Tryptophan 
Tyrosine 
VaLine 
-2-
PART  II  - CASEIN 
g/100g  of  protein 
3.7 
0.3 
2.9 
5.4 
9.5 
8.1 
2.8 
5.2 
4.7 
1. 6 
5.8 
6.7 ANNEX  VII 
CONCENTRATIONS  OF  MINERAL  ELEMENTS  IN  COWS'  MILK 
For  guidance,  the  concentrations  of  mineral  elements  in  cows•  milk 
are  as  folLows: 
Sodium  (mEq) 
Potassium  (mEq) 
Chloride  (mEq) 
Calcium  (mg) 
Phosphorus  (mg) 
. Magnesium  (mg) 
Copper  )Mg) 
Iodine 
per  100g  of  fat-free 
dry  matter 
24 
43 
30 
1350 
1070 
135 
225 
Not  specified 
per  1g  of  proteins 
0.65 
1.10 
0.80 
35 
28 
3.5 
6 
Not  specified REPORT  ON 
INFANT  FEEDING  AND  THE  IMPLEMENTATION  OF  THE  INTERNATIONAL  CODE 
OF  MARKETING  OF  BREAST-MILK  SUBSTITUTES 
1.  Introduction 
The  Commission  of  the  European  Communities  has  for  some  time 
now  been  studying  the  subject  of  infant  feeding.  In  this  the 
Commission  was  prompted  by  international  interest  and  by  the 
fact  that  the  Community  is  competent  to  regulate  on  the  qua-
litative  asp~cts of  foodstuffs  intended  for  the  particular 
nutritional  use  of  infants  and  young  children. 
1.1.  In  the  late  1970s  the  subject  of  infant  and  young  child  fee-
ding  received  much  attention.  At  the  origin  of  this  interest 
there  were  reports  compiled  by  various  non-governmental  or-
ganisations  describing  the  marketing  practices  for  the 
promotion  of  breast  milk  substitutes  to  the  detriment  of 
breast-feeding  and  denouncing  the  effects  these  practices 
had  on  the  health  of  infants  particularly  in  the  developing 
countries.  In  October  1979  WHO  and  UNICEF  organised  a  joint 
meeting  on  the  subject  in  Geneva.  Representatives  of  indust-
trialised  and  developing  countries,  of  the  relevant  sector 
of  industry,  of  non-governmental  organisations,  of  the 
Commission  of  the  European  Communities  and  experts  in 
related  disciplines  participated.  The  discussions  were  orga-
nised  on  five  main  themes:  the  encouragement  and  support  of 
breast-feeding;  the  promotion  and  support  of  appropriate  and 
timely  complementary  feeding  practices  with  the  use  of  local 
food  resources;  the  strengthening  of  education,  training  and 
information  on  infant  and  young  child  feeding;  the  promotion 
of  the  health  and  social  status  of  women  in  relation  to  in-
fant  and  young  child  health  and  feeding  and  the  appropriate 
marketing  and  distribution  of  breast-milk  substitutes. -2-
In  this  meeting  a  series  of  recommendations  relating  to  in-
fant  feeding  were  formulated  among  which  that  "there  should 
be  an  international  code  of  marketing  of  infant  formula  and 
other  products ·used  as  breast-milk  substitutes"<1>. 
In  May  1981  the  final  draft  of  the  International  Code  was 
presented  to  the  34th  World  Heal.th  Assembly  in  the  alterna-
tive  forms  of  a  regulation  and  a  recommendation.  It  was 
adopted  as  a  recommendation  by  118  votes  in  favour,1  against 
and  3  abstentions.  During  the  debate  at  that  meeting  the 
Community  and  its  Member  States  stated  (Annex  1)  that  they 
w  e r e  i n  f a v  0 u r  0 f  t h e  c 0 d e  a s  a  r e c  0 m  m  e n d a t i 0 n  a n  d  t h a t  t h·e y 
fully  subscribed  to  its  aims.  With  regard  to  its  implemen-
tation  they  pointed  out  that  in  the  past  action  had  already 
been  taken  to  achieve  several  of  these  aims  within  the 
Community.  For  other  parts  of  the  Code  it  was  stated  that 
the  Community  and  its  Member  States,  as  appropriate,  would 
endeavour  to  give  effect  to  the  principles  and  goals  set  out 
therein,  having  regard  to  their  constitution,  laws  and 
social  struc~ures~  A  second  statement,  to  the  same  effect, 
was  made  at  the  36th  World  Health  Assembly.  (Annex  II). 
1.2.  With  two  resolutions,  in  October  1981  ( 2)  and 
April  1983  (3),  the  European  Parliament  called  on  the 
Commission  to  submit  to  the  Council  a  proposal  for  a 
directive  on  the  application  of  the  International  Code  and 
to  make  all  reasonable  effo.rts  to  ensure  that  companies 
based  in  Member  States  and  operating  in  developing  countries 
comply  with  the  provisions  of  the  International  Code  or 
Local  legislation  and  codes  in  developing  countries. 
2.  The  situation  of  infant  feeding  in  the  Community  in  relation 
to  the  aims  of  the  International  Code 
Apart  from  these  cases  where  medical  or  other  imperative  cir-
cumstances  remove  all  element  of  choice  the  decision  whether 
(1)Resolution  WHO  33.32  Infant  and  young  child  feeding. 
(2)0J  No  C  287/75  of  15.10.81. 
(3)0J  No  C  128/16  of  16.5.83. 
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to  breast-feed  or  not  is  an  intensely  personal  one  taken  by 
each  mother  usually  before  birth.  In  the  Community  the  high 
degree  of  development  of  the  health  services,  the  activities 
of  voluntary  groups  and  extensive  public  debate  in  the  media 
ensures  that  the  majority  of  mothers  are  aware  of  and  are  able 
to  appreciate  the  considerable  advantages  of  breast  feeding 
before  making  their  decision.  Amongst  the  factors  which  can 
influence  their  choice  are,  health  status,  whether  the  mother 
works  or  not,  her  working  conditions,  her  level  of  education, 
information,  advice  and  assistance  she  receives  during 
pregnancy  and  during  her  stay  in  the  maternity  clinic  after 
birth  by  health  professionals,  opinions  expressed  by  the  close 
environment  (relatives,  friends).  Marketing  and  distribution 
of  breast  milk  substitutes  is  another  factor  but  in  an  in-
formed  society  by  no  means  the  most  important.  It  should  be 
noted  here  that  studies  and  research  are  currently  under  way 
to  assess  the  Level  of  contamination  of  human  milk  by  various 
chemicals  and  in  different  settings,  and  to  assess  the  health 
significance  of  these  levels  of  contamination. 
The  aim  of  the  International  Code  as  spelt  out  in  its  first 
article  is  to  contribute  to  the  provision  of  safe  and 
adequate  nutrition  for  infants,  firstly  by  the  protection 
and  promotion  of  breast-feeding  and  secondly,  by  ensuring 
the  proper  use  of  breast-milk  substitutes  of  appropriate 
quality,  when  these  are  necessary. 
The  main  areas  dealt  with  in  the  International  Code  can  be 
identified  as 
- the  education  and  information  of  the  general  public, 
mothers  and  health  workers, 
- the  conduct  of  health  care  systems 
-the marketing  practices  for  breast-milk  substitutes  and 
- their  labelling  and  quality. -4-
2.1.  Education,  information  and  the  conduct  of  health  care 
systems 
Measures  concerning  information .and  education  on  the  parti-
cular  subject  and  the  conduct  of  health  care  services  are 
essentially  the  responsibility  of  National  Authorities  of 
Member  States.  The  Latt~r  have  recognised  the  importance  of 
breast-feeding  Long  before  the  development  of  the  Interna-
tional  Code  and  they  have  undertaken  active  campaigns  for 
its  protection  and  promotion. 
Social  measures,  which  are  not  covered  by  the  International 
Code,  include  special  maternity  Leave  which,  in  many  cases, 
is  flexible  and  its  greater  part  can  be  taken  after  the 
birth.  In  some  countries  this  leave  can  be  extended  without 
pay  with  guarantee  of  the  post  of  employment  and  financial 
assistance  is  provided  by  the  State  during  this  period  of 
leave. 
In  some  countries  mothers  of  infants  and  young  children  have 
reduced  working  hours  or  are  allowed  breaks  during  work  to 
give  them  the  possibility  t6  continue  to  breast-feed  their 
babies.  The  provision  of  breast-feeding  breaks,  together 
with  the  provisi~ns of  creches  in  the  places  of  employment 
is  under  consideration  by  other  Member  States. 
Most  of  the  efforts,  though,  have  been  concentrated  in  the 
field  of  education  and  information.  Such  action  has  been 
directed  at  health  care  systems  and  the  public. 
In  the  U.K.,  for  example,  the  attent~on of  health  care 
systems  and  health  workers  had  been  drawn  to  the  benefits 
of  breast  feeding  in  the  past  by  publications  such  as 
"Reducing  the  risk"  (1977),  "Breast  Feeding"  (1978),"Eating 
for  Health"  (1978)  and  "Present  day  Practice  in  Infant 
feeding"  (1980),  to  cite  as  an  example  the  United  Kingdom. -5-
Health  circulars  reaffirming  the  Member  States  Authorities• 
commitment  to  the  promotion  of  breast  feeding  have  been 
circulated  to  health  care  systems  following  the  publication  . 
of  the  WHO  Code.  In  these  the  responsibilities  of  health 
care  personnel,  covered  by  specific  provisions  of  the  WHO 
Code,  are  stressed.  The  importance  of  the  advice  given  to 
mothers  regarding  infant  feeding  practices  is  underlined. 
The  aim  is  to  enable  mothers  to  make  an  informed  choice 
about  the  method  of  feeding  their  babies.  Maternity  clinics 
are  ehcourag~d to  put  into  practice,  whenever  possible, 
current  concepts  which  will  help  the  establishment  of 
breast-feeding  such  as  immediate  contact  between  the  mother 
and  the  baby  after  delivery,  "rooming  in"  of  mothers  and 
babies  and  the  possibility  of  feeding  the  baby  "on  demand" 
if  the  mother  so  wishes.  Guidelines  for  the  distribution  of 
samples  of  breast  milk  substitutes,  when  necessary,  are 
also  provided. 
In  order  that  the  health  workers  are  best  able  to  carry 
out  their  duties,  measures  are  taken  or  are  under  study  to 
include  in  the  curricula  of  health  personnel,  as  priority 
subjects,  principles  of  nutrition,  nutritional  needs  of 
mothers  and  infants,  the  advantages  of  breast  feeding  over 
artificial  feeding  and  the  appropriate  use  of  breast  milk 
substitutes  when  these  are  necessary.Further  measures  aim 
at  the  provision  of  in-service  training  and  refresher 
courses  for  improving  the  continuous  education  of  doctors, 
health  visitors  and  midwives.  This  formal  training  is 
supplemented  by  leaflets  and  posters  containing  appropriate 
information,  which  are  published  by  the  Health  Authorities. 
Education  and  information  of  future  mothers  and  mothers  is 
extremely  important.  They  are,  after all,  the  ones  to  make 
the  final  decision.  The  importance  attached  to  it  is  well 
illustrated  by  the  fact  that  certain  Member  States  have 
carried  out  or  are  in  the  process  of  carrying  out  surveys 
on  the  frequence  of  breast-feeding,  its  duration,  the  phy-
siological,  socio-economic  and  enviromental  factors 
affecting  breast-feeding.  In  Ireland  one  of  these  surveys 
has  identified  also  the  media  preferred  by  mothers  for  re-
ceiving  information  on  nutrition.  The  results  of  these 
surveys  provide  baseline  information  for  planning  further -6-
public  education  programmes. 
At  present  primary  sources  of  education  are  the  health  per-
sonnel  of  ante- and  post-natal  clinics  and  of  maternity 
clinics.  Their  responsibilities  and  their  importance  have 
been  outlined  aboveL 
Another  equally  important  source  are  booklets,  Leaflets  and 
posters  produced  by  Health  Authorities  and  made  available 
through  the  health  care  systems  free  of  charge.  These  pu-
blications  contain  ~omprehensive  information  on  maternal 
nutrition,  infant  nutrition,  the  superiority  and  bene~its of 
breast-feeding,  how  to  establish  and  maintain  breast-
feeding,  the  proper  use  of  breast  milk  substitutes  when 
these  are  necessary  and  other  information  on  baby  care. 
Special  attention  is  given  to  particular  population  groups 
such  as  ethnic  minorities,  where  these  exist.  In  Germany, 
for  example,  a  60-page  publication,  "Das  Baby",  is  published 
also  in  Greek,  Italian,  Portuguese,  Serbo-Croatian,  Spanish 
and  Turkish.  In  the  United  Kingdom  the  Government's  Asian 
Mother  and  Baby  Project  has  the  responsibility  of  informing 
this  special  group. 
The  Authorities  in  Member  States  provide  various  means  of 
assistance,  including  financial  support,  to  a  number  of  vo-
luntary  organisations  which  promote  breast-feeding.  The 
contribution  of  these  organisations  towards  this  goal  is 
indeed  considerable.  They  diffuse  a  plethora  of  information 
through  Leaflets,  Lectures,  etc. 
Regarding  the  education  and  information  of  the  public  at 
Large,  professional  bodies  and  n6n-governmental  organi-
sations  publish  articles  in  the  Press  which  cover  certain 
needs  in  this  field.  The  Health  Circular  to  Health  Autho-
rities  in  the  United  Kingdom  notes  that  health  education 
officers,  school  doctors,  health  visitors  and  school. nurses 
will  have  a  role  to  play  in  spreading  ~ppropriate infor-
mation  among  young  people  in  the  context  of  preparation  for 
parenthood.  This  may  mark  a  trend  in  developments  in  the 
area  of  health  education  of  the  public  in  general. -7-
2.2.  Marketing  practices 
Marketing  according  to  the  International  Code  means  product 
promotion,  distribution,  selling,  advertising,  product 
public  relations  and  information  services.  Marketing  cam-
paigns  are  planned  by  manufacturers.  But  because  of  the 
nature  of  these  products  there  is  a  close  link  between  the 
health  po(~iies  and  the  organisation  of  health  care  systems 
in  this  area  in  the  various  Member  States  and  the  way  in 
which  these  products  are  marketed.  Thus  national  autho-
rities  exercise  control  over  the  marketing  practices  for 
these  products.  But  apart  from  differences  in  traditions 
and  customs  there  are  other  differences  which  influence 
marketing  practices.  For  example  a  total  ban  on  advertising, 
as  advocated  by  the  International  Code,  would  be  contrary  to 
the  constitution  of  several  Member  States. 
All  Member  States  are  in  favour  of  voluntary  agreements  for 
the  control  of  the  marketing  practices  for  breast-milk 
substitutes.  National  Federations  of  Manufactures  have 
expressed  their  willingness  to  set  up  such  voluntary  codes 
of  practice  for  implementing  the  aims  and  principles  of  the 
WHO  Code  in  a  way  which  is  appropriate  to  national 
circumstances.  In  Ireland,  the  United  Kingdom  and 
Denmark  such  voluntary  codes  were  developed  in  consultation 
with  the  responsible  authorities  and  they  are  already  in 
operation. 
going  on. 
In  other  Member  States  consultations  are  still 
At  Community  Level  manufacturers  have  been  making  consi-
derable  efforts  to  elaborate  a  voluntary  code  of  conduct. 
The  Association  of  Dietetic  Foods  of  the  EEC  (ICACE)  sent 
to  the  Commission  in  April  1982  a  first  draft  of  a  voluntary 
code  of  practice  for  the  marketing  of  breast  milk  substi-
tutes  agreed  by  the  manufacturers  of  the  Community,  which 
was  followed  by  a  new  draft  in  December  1982.  The  Com-
mission  felt  that  it  would  be  very  useful  for  the  Member 
States  and  other  parties  concerned  within  the  Community 
to  be  able  to  comment  on  the  IDACE  draft  voluntary  code. 
This  was  done  in  meetings  with  Member  States  and  within 
the  Advisory  Committee  fo~  Food,  which  took  place  in -8-
March/April  1983  and  October  1983.  During  these  meetings 
the  Member  Sates  expressed  firm  support  for  voluntary 
measures  for  the  regulation  of  the  marketing  practices  of 
breast  milt  substitutes.  However,  they  made  numerous 
comments  and  suggestions  for  the  improvement  of  the  IDACE 
proposals.  The  four  of  the  five  groups  represented  in  the 
Advisory  ·Committ~e  for  Food,  namely  Agriculture,  Commerce, 
Industry  and  Workers,  w~re  also  in  favour  of  the  voluntary 
approach  and  thought  that  the  IDACE  draft  was  a  good  basis 
for  discussions.  The  other  group,  Consumers,  expressed  their 
opposition  in  principle  to  voluntary  measures,  but  partici-
pated  fully  in  the  discussions,  made  most  of  the  suggestions 
for  the  improvement  of  the  IDACE  code  and  were  generally 
satisfied  with  the  final  compromise.  IDACE  communicated  the 
final  version  of  their  voluntary_ code  to  the  Commission  in 
January  1984  (Annex  III). 
The  IDACE  code  relates  to  the  marketing  practices  of  infant 
formulae,  which  are  the  only  ones  marketed  as  a  breast  milk 
substitute  for  the  first  few  months  of  life.  It  takes  into 
account  the  individual  constitutions,  laws,  social  struc-
tures  and  relevant  policies  of  Member  States  and  therefore 
represents  a  general  requirement  for  the  Community  area, 
not  excluding  specific  national  measures  existing  or  being 
ad6pted.  The  IDACE  code  covers  the  conduct  of  manufacturers 
only.  However,  the  manufacturers  undertake  not  to  infringe 
this  code  indirectly  by  inciting  third  parties  or  by  pro-
viding  them  the  means  for  doing  so.  After  careful  conside-
ration  of  all  the  factors  which  influence  the  marketing 
practices  for  breast-milk  substitutes  in  the  Member  States, 
the  Commission  is  convinced  that  the  flexibility  offered  by 
a  voluntary  agreement  is  the  best  way  to  control  these 
practices.  The  Commission  will  consider  again  this  position 
in  the  light  of  experience  gained  from  the  operation  of  the 
IDACE  code. 
The  Commission  is  strongly  in  favour  of  the  principle of 
monitoring  the  operating  of  the  IDACE  code  which  is  unlikely 
to  inspire  sufficient  co~fidence unless  it  is  seen  to  be 
under  independent  scrutiny.  However,  the  responsibility  of 
setting  up  and  the  composition  of  a  monitoring  committee  are -9-
still  under  consideration  and  the  text  of  Article  11.2  of 
the  !DACE  code  should  therefore  be  considered  provisional. 
2.3.  Quality  and  Labelling 
The  composition  and  Labelling  of  infant  foods,  is  covered  by 
Article  9  and  10  of  the  International  Code.  This  matter  can 
be  regulated  through  Article  1(3)  of  Council  Directive 
77/94/EEC  on  the  approximation  of  the  laws  of  the  Member 
States  relating  to  foodstuffs  for  particular  nutritional 
uses,  which  states  that  the  Council  shall,  by  means  of 
directives,  adopt  the  provisions  applicable  to  certain 
groups  of  products,  among  which  are  foodstuffs  for 
particular  nutritional  use  of  infant  and  young  children  in 
good  health. 
The  Commission  asked  the  Scientific  Committee  for  Food  to 
give  its  opinion  on  the  essential  composition  of  infant 
formulae  and  follow-up  milks.  On  the  basis  of  this  opinion, 
which  was  expressed  in  April  1983,  and  in  consultation  with 
Member  States  Government  experts  and  the  Advisory  Committee 
for  Food,  the  Commission  drafted  a  proposal  for  a  Council 
Directive  on  the  composition,  labelling  and  certain  aspects 
of  advertising  of  infant  formulae  and  follow-up  milks  which 
is  submitted  to  the  Council  together  with  this  report. 
3.  The  implementation  of  the  International  Code  in  developing 
countries 
The  Commission  considered  carefully  the  request  of  the  Euro-
pean  Parliament  to  make  all  reasonable  efforts  to  ensure  that 
companies  based  in  Member  States  and  operating  in  developing 
countries  comply  with  the  provision  of  the  International  Code 
or  local  legislation  and  codes  in  developing  countries. 
It  agrees  with  the  points  of  view  expressed  by  the  European 
Parliament  that  real  problems  of  malnutrition  of  bottle-fed 
babies  exist  essentially  in  developing  countries  where  the 
limited  purchasing  power  of  parents  does  not  permit  the 
regular  provision  of  sufficient  quantities  of  breast  milk 
substitutes  and  where  the  hygienic  conditions  necessary  for -10-
the  correct  preparation  of  these  substitutes  are  more 
difficult  to  obt~in. 
It  is  very  important  that  marketing  practices  in  developing 
countries  should  not  discourage  mothers  from  breastfeeding. 
It  is  the  responsibility  of  the  competent  authorities  of  these 
countries  to  make  sure  that  this  principle  is  respected. 
The  Commission  in  its  effort  to  offer  them  effective  support 
proposes  the  adoption  of  a  Council  Resolution  on  the  subject 
<Annex  4).  The  system  envisaged  therein  is  both  flexible  and 
efficacious.  At  the  same  time,  extra-territorial  measures 
which  are  Legally  doubtful  are  avoided. 
The  Commission,  on  the  other  hand  proposes  that  certain  la-
belling  requirements  concerning  the  products  covered  by  the 
attached  proposal  for  a  directive  should  also  apply  for 
products  being  exported. 
The  Commission  finally  draws  attention  to  the  fact  that  the 
!DACE  industries  have  agreed  to  observe  voluntarily  that  "all 
exported  infant  formulae  will  meet  internationally  recognised 
standards  of  quality,  unless  the  recipient  countries  have 
specific  national  standards  or  particular  nutritional  require-
ments  which  have  to  be  complied  with". 
4.  Conclusions 
In  conclusion  the  Commission  believes  that  the  response  of  the 
Community  to  the  International  Code  has  to  be  a  balanced  one 
which  makes  the  most  effective  use  of  the  different  means 
available  to  achieve  the  objectives  of  the  Code.  The  variety 
of  interrelationships  between  education,  information  and 
health  care  syste~s  in  the  Member  States  reflect  the  different 
social  tradition~  in  a  questicin  in  whith  p~rsonal  contact  and 
relationships  are  extremely  important.  The  Commission  is 
pleased  to  note  the  achievements  of  the  various  ~uthorities 
and  voluntary  bodies  and  considers  that  discuision  and  ex-
change  of  experience  at  Community  level  can  provide  a  useful 
stimulus  to  further  progress. -11-
The  cooperation  of  industry  both  in  respect  of  the  voluntary 
code  within  the  Community  and  their  engagement  of  the  quality 
of  exported  products  has  enabled  a  solution  to  be  achieved 
much  more  rapidly  than  it  could  have  if  the  Community  had 
proceeded  by  using  mandatory  instruments.  The  effectiveness  of 
this  public  commitment  by  industry  is  reinforced  by  their 
declared  willingness  to  keep  the  operation  of  the  code  under 
continuous  review  in  cooperation  with  public  authorities  and 
consumer  bodies. 
Finally  the  directive  on  the  composition,  labelling  and 
certain  aspects  of  advertising  of  infant  formula  and  follow-
up  milk  will  give  added  assurance  to  the  consumer  that  the 
product  concerned  is  of  appropriate  quality  whilst  removing 
barriers  to  trade  in  an  important  area  of  foodstuffs. ·-
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PRESEUTED  BY  THE  ilORLD  HEALTI-i  ORGAJiiZA'l-ION 
~'h<::  \;,:>:v.muni ty  and its !'!ember  States  are  in favour  of the draft  Code  presented  in  the 
fonn  of a  recor;<.-:~endation of the  World  Health Organization. 
l. He  have  examined  the  Code  very closely and it is clear that  we  sutscri  be  full~· to  its 
aims 1  namely the "provision of safe  and  adeqUate nutrition for  infal"lts".  He  also 
consider that breastfeeding must  be  encouraced  as  an  .  .1m~01allcd \:a:y  of contritatinz 
to  the  achicve:nent  of this  aim.  On  the other hand,  \:here  brcastfeedi~G cz:..'1.Ilot  be 
ensured,  it is essential that breaitmilk substitutes should be  used  under  opti~.wn 
condi"tions, 
2,  ',I,;;  chould  also  like to  emphasize  that  the  Code,  which,  as  I  have  just  sq.id,  is csscnti 
Bhould  be  seen  in  a  r:Jore  general  and  broM.er context.  It should  be  recocnized.  cos  bcin{ 
oPe  of  a  variety of features  of the  policy  ..>arried  out  by  the  \n!O,  the  aim  of  \<rhicl"l  is 
to  i:nprove  the  health situation of mothers  and  young children  throughout  the world. 
:..  A:.3  l'Cga!'ds  the_  impl~menta.tion of the  Code,  it should firstly be  pointed out  that  witt~ 
the  Corr:euni ty,  several of the  aims  of the  Code  have  in the  past  rcacned  the  sta.;:~  r  •· 
tcing put  into practice.  As  regards  other parts of the  Code,  the  Co1.1r.1unity  and  its 
· JkrJl>cr  St2.tes,  as  the case may  be,  will  endeavour  to  give  effect  to  the  principles  an:: 
«i:ns  exp1·c::;:>8d  as  appropriate  to their constitutional  and  lcgiolative  fril!Tlcuori:  c.s 
'.Jell  as  their ::;ocial  situations;  It goes  Hithout  scyi.ng  th<:tt  the  ~-lorld  Health  Or[i!n-
ization will  be  K.ept  informed of further  action  taken  on  the  Code  by  the  Conu:Junity 
ru1d  its Member  States, 
4.  In  c.onclmion,  I  should  like  to reiterate our .commitment  to  the  cuidinG  principle::; 
ex-prt:E;Zcd  in the  Code  and  to  thank  the  \-1110  vnd UUICEF  on  behalf of the  Cofllrj\uni t_: 
fl!l.d  iin Member  States  for the initiative they  have  taken.  He  nust  nou  proccE:d  u::.Lh 
the  phu.sc  of  practic.:~.l  imple;-:-.cntation  and  c-ain  more  experience.  After  a  few  ye<J.:-s, 
it vrill  in  any case be  ncccssc;.ry  to  meet  aeain  and,  in  the lieht of tho  r.xpcri<;:1cc 
~aincd in  the  rneam1hile  1  to  revise  and  i!:lprove  one  or other  scct~on of the  Code~ 
An  far  <l!l  He  are  concerned,  I  can  confinn here  Md  now  that  you  may  be  (!;.;:::urcd  of 
ou.r  collaboration when  that  occasion arises  0  . 
Pre~s unCI  Information OH•ce  of ttle  EC  ComnuS$iO·n- 31-39, rue de  Vermont. cue 195,  1211  Geneve 20 
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European 
Community 
Press  Release 
WHO  - 34th  World  Health  Assembly 
STATEMENT  OF  THE  DELEGATION  OF  THE  FEDERAL  REPUBLIC  Of  GERMANY 
ON  BEHALF  OF  THE  EUROPEAN  COMMUNITY  AND  ITS  MEMBER  STATES 
-------------
(10  May  1983) 
On  behr:.Jf  of  the  European  Community  nnd its l:lembc:r- States 
I  have  the honour to make  the  following statement: 
·1.  /1  l  the  3'1 th  World  Health  ll~;:::;cmbly  the  J:>J.l'OJ1Can  Eccnomic 
Gomnnuri i.)r  nnd  its Member S t.n tes fully endorsed  the  aims 
pursued by  the  Internatiorwl Code  ol' Marketing of Brcnst-7.1i.J.k 
SulJ!;Mtutes.  With  regard  to its  iiD}Jlemcntation,  tl1ey  pointcci 
cut- that  i.n  the past uction had alrcad:,•  been  tal~en  tt.>  achieve 
~H.~ vcr;;:_l  of these  aim~~ within the  r.orr:.inunit~r.  For  other parts 
of  thn  Code,  it was  s tv. ted  that the  Corrum.mi ty c.nd  its 
M.c·mb,~1· States,  as  Dppropria  tc,  wou:td  endt::e:-.vour  to  g:i.-vc 
r~fi"ect  to  the  pril)(;iplc3  ao:l  goal:3  ::.et  out  the:cein,  lwdng 
rer,tt:t·d  to  their const.itution,  laws  und _s·o9iul  !.>tructul'es  ~ 
c orH;erTw d  \vj_ th inforrnl.i tiun  and education,  health  ca:ce 
systems,  health workers  and persons  cwploycd  b:{ ·the  i:ndw:>tx·y 
urc prjmarily the  responriibility  o~ tbe  Member  St~tes. 
to  thes(~ 110ints  t~oe9 not nccesstlrily cull  :for  tht~  c.t"iupt:i vn 
o:r  J.e.vt!J  or  r<-~t;-v.ln:t.:i.ons  ty  the  Mcmhel"  Stb.tes  bkt  <:<!21  b<.::  J.or:e 
-l-\.l'Ol'-1  1·- ,~..J>·,··(  .....  ]~"~··-·  ... _·Tr.l  ...... rr":J····urc'"'  •·.d.  "·f!,-l  llCfl·-.!.cE,J  . ..:.  _, .•  l..L~..,  .w-::,~.,  .,.,  In  ~cvcrnl Memb~r States 
oevelopcd.. 
p-;;~·;,,d  lnfor~-;;~;~11 Office of the  EC  Commission - 37-39, rue  de  Vermont,  case  196.  121 1 Genltve  20 
Telephone  34 97 50- Tale:c  28281  ECOM  CH 
. ..  I ... 2.2. It should also  be  noted that the  Commission  of the  Jfu.ropean 
Communities  is examining n  draft  volun~ary code  of practice 
for the  marketing of breast-milk substitutes Xihich  was 
prepared  by  the Association of Dietetic  Foods  Industries 
of the  LUropean  EConomic  Community.  This-draft is still 
under consideration. 
3.  ~l'hc  Community  as  un  entity is responsible!  for  rcgi.l.J.n.ti.ng 
\mdcr the  international Code: 
(c.)  the  composit:ion  oi·  brc<:!st-m:iJJ~ Dilbstitutes, 
(b). their labelling and certain aspects  concerning 
advert:i.singo 
3.1 o  As  far as  the  composition  of b:reast-milk substi  tutcr:: 
.. 
is conccn1ed,  the Scientific  Committee  for  }'ood  has 
bc8n  as}.:.ed  to  wake  recommendations  ·i,o  serve  as  the  bas:i s 
for future. Commv.ni ty regulations.  The  Corrm:i ss:i.on  of the 
European Communities  wiJ.l.of course  se:nd  the  WHO  uny 
texts drafted in this respect. 
3.2.  The  future  Community  regulations must  also  cover  the 
labelling  ~f breust-milk_ substi  tutc~;.  ·For this,  the 
International Code  will serve  as  a  rc~erence  doc\~8nt. 
It should be  noted  tl1at any labelling or advertising 
likely to  bs  misleading is already prohibi-t'ed  by 
Community  regulations •. 
4.  In  summary,  "the  l!.'uropean  Economic  Comm'..L1i ty and its 
Member States welcome  this comprehensive  report by  the 
Director General and  share his view,  that it;  would  be 
premature,  at this stac;e,  to px·o_pose  cmy  amenr1rnent~•  to 
the  Code~ 83/200  (1) 
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PREAMBLE 
INDUSTRY  CODE  Of  PRACliCE  FOR  THE  MARKETING· 
OF  BREAST  MILK  SUBSTITUTES  IN  THE  EEC 
ANNEX  3 
i.  0  A  C  E 
The  National  Associations of manufacturers  of dietetic  foods,  including 
mantJfacturers  of  foods  for  infants  and  young  children,  constituting 
IUACE,  agree  to establish  the  following  Code  of Practice concerning  the 
marketing  of breast-milk substitutes,  following  consultation with  the 
European  Commission,  and  the  EEC  Advisory  Committee  on  Foodstuffs 
representing  the various sectors concerned. 
The  pre-eminent  role of breast-feeding is  recognized,  and  it is  in  the 
interest of mothers  to breast-feed their babies. 
It is considered that  mothers  should  not  be  discouraged  from  breast-feeding 
their babies  and  th8t  any  promotional  activity which  may  be  of a  nature 
to  suggest  that  feeding  babies  w1th  a  breast-milk substitute is in  any 
way  preferable to breast-feeding,  should  be  avoided. 
V.'h~.'n  mothers  do  not  breast._feed,  or only  do  so partially,  there  is a  need 
fer  nutritionally adequate  breast-milk. substitutes  formulated  in  accordance 
with  EEC  or nations!  standards. 
The  development  of  nutr.i Lionally  adequate  breast-milk  substi lutes has  resulted 
from  traditional co-operation  between  manufact~rers, universities,  p~edia­
tricians,  maternity  hospitals,  clinics and  governments  ;  and  such  co-operation 
must  continue  to  play  an  i1nportant  role  in  the  research,  formulation,  and 
recorrmendation  of  these  products  in order  to  ensure  the  supply  of high 
quality  products backed  by  a  guarantee  of maximum  safety. 
(1)  replaces 82/130  and  83/150  . ..  I ... ...  I ...  -2- A 3--
!DACE,  representing  the dietetic  food  industries  in  the  Member  States of 
the  European  Community,  its constituent National  Associations,  and  their 
individual  member  companies,  is convinced  that it must  continue to have 
the obligation to act  in accordance  with  the  recommendations  of the  medical 
profession,  and  the  needs  and  interests of  the  users  and  final  consumers 
of breast-milk substitutes,  and  in compliance  with  the national  legislation 
in  force  in  each  Member  State of  the  EEC. 
It is with  these principles in mind  that  1DACE  has  drawn  up  the  following 
voluntary  Code  of Practice  for  the  Marketing  of Breast-Milk Substitutes in 
the  EEC. 
This  voluntary  code  is intended  to give effect  to  the  principles  and  aims 
bf the  WHO  International  Code  of Marketing  of Breast-milk Substitutes,  as 
appropriate  to  the constitutional  and  legislative  framework  and  the social 
structures of the  EEC  Member  States,  and  relevant  to  the  needs  of mothers 
and  babies.  It relates  to  the  marketing  practices mentioned  in  the  WHO  Code 
which  are  applicable  in  the  EEC  and  over  which  manufacturers  have  direct 
control.  It does  not  include those elements of the  WHO  Code  which  are  the 
responsability of health services. 
The  Code  applies  to breast-milk substitutes as  defined  in article 3,  i.e. 
infant  formulae  only,  because  the latter are .th~ only  products nutritionally 
suitable to  replace breast-milk before weaning  and  are consequently  the sole 
products marketed  for  this purpose  within  the  social  and  legislative  frame-
w.ork  of  the  EEC. 
It is  recognized  that this voluntary  code  is a  minimum  requirement,  which 
does  not  exclude specific national  measures  existing or  being  adopted.  This 
Code  does  not  take  precedence  over  national  or  EEC  legislation  . 
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CODE 
The  National  Associations of Manufacturers  of Dietetic Foods  nf the  EEC, 
constituting  IDACE 1  hereby  agree  the  following  articles as  a  Code  of 
Practice within  tho  EEC,  for  all manufacturers  marketing  breast-milk 
substitutes in the  EEC. 
ARTII:LE  1  AIM  Of  THE  CODE 
[he  aim  of this Code  is to contribute  to  the  provision of safe  and  adequate 
r1utrition  for  infants,  by  the  protection  and  promotion  of breast-feeding, 
and  by  ensuring  the  proper  use  of breast-milk substitutes '<'lhen  these  are 
necessary,  on  the  basis of adequate  information  and  through  appropriate 
marketing  and  distribution. 
ARliCLE  2  SCOPE  Of  THE  CODE 
The  Code  applies to  th~ marketing  in  the  EEC,  and  practices related thereto, 
of breast  milk  substitutes marketed  as  suitable  for  the  sole source of 
not!rishment  for  an  infant  during  the  first months  of life.  It also applies 
to  information concerning  their use. 
ARTICLE  3  :  DEFINITIONS 
"Breast-milk substitute "  means  :  an  .infant  formula  formulated  industrially 
in  accordance with  EEC  standards  or  appropriate national  standards,  as 
suitable  for  use  as  the sole source of nourishment  and  to satisfy the  normal 
nutritional  requirements  of infants  from  birth on  and  during  the  first 
months  of life,  and  adapted  to  their physiological characteristics.  It does 
not  include  weaning  foods  or  follow  up  milks  when  marketed  for  use  as  a  part 
of a  mixed  diet during  the  time  when  breast-feeding or  feeding  with breast-
milk  substitutes begins  to be  replaced. 
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"Health services" means  :  governmental  or  private institutions or  organi-
zations engaged,  directly or  indirectly,  in health care  for  mothers,  infants 
and  pregnant  women,  nurseries and  child-care institutions. 
"Health professional"  means  :  a  professionally qualified person  working  in 
a  component  of the  health services. 
"Manufacturer"  means  :  a  person,  corporation or  any  other entity engaged 
in  the  business or  function  (whether  directly or  through  an  agent  or  through 
an  entity controlled by  or  under  contract  with  it) of manufacturing  breast·· 
milk  substitutes. 
"Marketing"  means  :  breast-milk substitutes promotion,  distribution,  selling 
advertising,  product  public  relations,  and  information services. 
"Marketing  Personnel"  means  any  person  whose  functions  involve  the  marketing 
of breast-ffiilk substitutes. 
"Monitoring Committee"  means  the committee  established in  accordance  with 
the  annexe  of this Code. 
"Public Mass  Media"  means  :  television,  radio,  cinema,  national  or  local 
newspapers,  billboards and  magazines  intended  for  the general  public.  It 
does  not  include professional  journals. 
"Samplesi'  means  :  single or small  quantities of breast-milk substitutes 
provided without  cost  to  the  recipient. 
"Labelling"  :  the definition according  to  the  labelling directive 
( 79/112/EEC). 
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ARTICLE  4  INfORMATION  AND  EDUCATION 
4.1  Information on  the characteristics and  use  of breast milk-substitutes 
may  be  providerl  by  manufacturers  for  use  by  families  and  others 
responsible  for  the care of infants,  when  in  conformity  with  the 
policies of  the  health services and/or  the  national legislation. 
4.2  Informational  and  educational  materials  whether  written,  audio  or 
visual  dealing  with  the characteristics and  use  of breast-milk 
substitutes should  always  : 
a)  state the superiority of breast-feeding, 
b)  avoid using  terms  which  might  discourage  breast-feeding, 
c)  avoid using  terms  which  could  cause concern  to mothers  who  are 
unable  or  unwilling  to breast-feed, 
d)  provide explicitly worded  and  illustrated  instructions 
to guide  mothers  on  the appropriate  and  correct  use of breast-
milk  substitutes, 
e)  stress the  importance  for  the baby's health of  following  feeding 
instructions carefully, 
f)  clearly identify  the product  concerned. 
4.3  Any  information or  educational material  provided by  manufacturers 
in  accordance with  articles 4.1  and  4.2,  should  be  available  to  members 
of the health professions and  to  those  members  of the  public  who 
request  it. 
ARTICLE  5  :  THE  GENERAL  PUBLIC  AND  MOTHERS 
5.1  Public mass  media  should  not  be  used  for  product advertising  of 
breast-milk substitutes to  the general public.  Product  advertising 
of breast-milk  substitutes is permitted in specialized consumer 
publications dealing with baby  care,  and  should be  in conformity 
with  the  requirements of article 4.2 a),  b),  c)  and  e). 
. ..  I ... ...  I ...  -6- A·.  ~ 
5.2  Point  of sale advertising dealing with  the characteristics and  the 
use of breast-milk substitutes should state the superiority of breast-
feeding,  avoid  using  terms  which  might  discourage breast-feeding ot 
cause  concern  t6 mothers  who  do  not  breastfeed and  should stress 
the  import~nce of  following  feeding  instructions carefully.  This  does 
not  apply  to  point of sale advertising consisting of the company  logo, 
product  identification,  company  or  brandname  and  price  indication. 
5.3  Samples  of breast-milk substitutes should  not  be  distributed  by 
manufacturers  to  pregnant  women,  mothers  of infants below  the  age  of 
3  months  or  their  families. 
5.4  .Utensils,  equipment,  or  other articles used  in  the preparation of 
breast.milk substitutes,  or other gifts used  to  promote  breast-milk 
substitutes,  may  not  be  given  by  manufacturers to pregnant  women, 
mothers  of infants below  the age  of 3  months  or  their  families. 
5.5  Marketing personnel,  in theii business capacity,  shoUld  not  seek 
direct contact with  pregnant  women  or  with mothers  of infants except 
when  requested  by  a  health professional  or  when  information is 
specifically requested by  a  consumer.  Information  provided  by  marketing 
personnel  must  conform  to  the  requirements of article 4,  where  appropriate. 
ARTICLE  6  :  INFORMATION  TO  HEALTH  PROFESSIONALS  AND  HEALTH  SERVICES 
6.1  Information and  educational materials published by  manufacturers  in 
conformity with  the  requirements  of article 4  may  be  pr6vided  to  the 
health services  for  use  at the discretion of health professionals. 
6.2  Information about  breast-milk substitutes provided  by  manufacturers 
to health professionals should  be  restricted to scientific,  factual 
and  practical matters  and  should  accurately  reflect current  knowledge. 
Such  information should not  imply  or  create  a  belief that  feeding 
with  a  breast-milk substi.tute  is equivalent  or superior  to breast-
feeding.  Information designed  for  use  by  health professionals  in 
instructing mothers  must  conform  to  the  requirements of article 4. 
Assistance may  be  provided by  appropriately  trained personnel  employed 
by  manufacturers only if requested  by  the health services concerned . 
. . .  I ... / 
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6.3  No  financial  or  material  inducement  to  promote  breast·milk substitutes 
should  be  offered by  manufacturers  to health professionals or  members 
of theit families.  Howevet,  inexpensive articles of general  utility 
fur  their professional  use  may  be  provid~d. 
6.4  Breast milk-substitutes and  utensils,  equipment  or other articles 
used  .in  the  preparat.ion of breast-m.iJk  substitutes may  be  supplied 
to  health professionals  for  use  at  their discretion in accordance 
with  national  health policies or  legislation,  notwithstanding  the 
provisions of article 5.3 and  5.4. 
6.5  Manufacturers of breast-milk subsitutes may  donate  equipment  and 
materials or  support  scientific activities including  fellowships, 
study  tours,  research  grants,  attendance at professional  conferences, 
provided  that  such  donations  are  not  conditional  on  the  recommendation 
of  br~ast-milk substitutes to  the  detriment  of breast-feeding.  Requests 
for  support  and  the decision  to grant  support  must  be  made  and  confirmed 
in writing.  Such  donations  may  only  be  made  if permitted under  the 
national  health policies or  national  legislation. 
ARTICLE  7  MARKETING  PERSONNEL 
7.1  Marrufacturers  should  apprise persons  employed  by  them  who  are  engaged 
in  the  marketing of breast-milk substitutes of the provisions  of this 
code  and  of their responsibilities under it. 
7.2  Persons  engaged  in marketing  breas~mi]k substitutes should  not  as  part 
of their  job responsabilities perform  educational  functions  in relation 
to  pregnant  womer1t  or mothers  of  infants except  as  provided  for  under 
<Jrtide  5.5. 
ARTICLE  B  LABELLING 
8.1  Labelling of breast-milk substitutes must  comply  with  the  relevant 
EEC  Directives as  implemented  into national  legislation. 
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ARTICLE  9  ·:  QUALITY 
9.1  Breast-milk substitutes must  conform  to  the quality  requirements  of 
the  relevant  EEC  Directives or  national  legislation. 
9.2  Foods  which  do  not conform  to  these quality  requirements  should  not 
be  labelled or  marketed  as  a  breast-milk substitute. 
ARTICLE ·10  APPLICA liON 
10.1  No  manufacturers  will  infringe this code  directly or  indirectly by 
inciting third parties or  by  providing  them  the means  for  doing  so. 
ARTICLE  11  MONITORING 
11.1  The.National  Associations of manufacturers  in each  Member  State of 
the  EEC  commit  themselves  to set  up  a  national  monitoring  committee 
in accordance  with  rules and  customs  relevant  to each  country.  The 
sanctions will  be  established in accordance  with  the  legislation 
in  force  in each  Member.State. 
11.2  For  alleged infringements  involving  the activities of a  manufacturer 
or manufacturers in more  than one  Member  State,  !DACE  proposes  to  the 
EEC  Authorities that  they  set up  a  supranational monitoring  committee 
made  up  of 7  members 
- a  person  recommended  by  the  EEC  Commission, 
- a  person  recom~ended by  the  European  Court  of Justice, 
- a  person  recommended  by  the  Consumer  Cohsultative  Com~ittee, 
- a  paediatrician, 
-_the President of  !DACE  or his representative,  and  two  other 
representatives of !DACE  of the  Member  States concerned • 
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The  rules of operat.ion  of this supra-national  monitoring  committee 
will  be  established with  the  mutual  agreement  of the  EEC  Authorities. 
The  Committee  will elect  its own  chairman. 
.• ANNEX  4 
COUNCIL  RESOLUTION 
oM  the  marketing  practi~es for  breast-milk  substitutes  in 
developing  countries  by  Comm~nity-based  manufacture~s 
THE  COUNCIL  OF  THE  EUROPEAN  COMMUNITIES, 
Having  regard  to  the  Treaty  establishing  the  European  Economic 
Community, 
Whereas  the  Commission  has  submitted  a  report  on  infant  feeding 
and  the  implementation  of  the  International  Code  of  Marketing  of 
Breast-milk  S~bstitutes  and  a  draft  proposal  for  a  Co~ncil 
directive  on  the  appr6ximation  of  the  laws  of  the  Member  States 
relating  to  infant  formulae  and  follow-up  milks; 
Whereas  in  May  1981  the  34th  World  Health  Assembly  adopted  as  a 
recommendation  the  International  Code  of  Marketing  of  Brea~t-mil~ 
Substitutes; 
Whereas  a  considerable  volume  of  these  products  are  sold  to 
developing  countries  by  Community-based  manufacturers; 
Whereas  it  is  considered  very  important  that  marketing  practices 
in  developing  countries  should  not  discourage  mothers  from 
breast feeding; 
Whereas  the  application  of  the  International  Code  provides 
without  doubt  an  excellent  way  to  achieve  this  in  these 
countries; Whereas  the  Community  cannot  legislate  for  these  countries; 
Whereas  the  Community  can  offer  an  effective  support  to  the 
competent  authorities  of  these  countries  in  their  efforts  to 
apply  the  International  Code  in  their  territory, 
HAS  ADOPTED  THE  FOLLOWING  RESOLUTION: 
1.  The  Community  will  contribute,  in  so  far  as  it  is  able,  to 
the  application  of  appropriate  marketing  practices  for  breast-
milk  substitutes  in  developing  countries. 
2.  For  the  implementation  of  point  1,  the  Commission  will 
instruct  its delegations  in  the  developing  countries  to  serve  as 
contact  points  for  the  competent  authorities.  Any  complaints  or 
criticisms  with  respect  to  the  marketing  practices  of  a 
manufacturer  based  in  the  Community  could  be  notified  to  them. 
3.  The  Commission  will  be  ready  to  examine  such  cases  and  to 
assist  in  the  search  for  a  satisfactory  solution  for  all  parties 
concerned. 
4.  This  resolution  shall  be  communicated  by  the  Commission  to 
the  countries  concerned  through  the  official  channels. 
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